My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Repligen Corporation - Common Stock (NQ:RGEN)

119.24 -0.53 (-0.44%)

Streaming Delayed Price Updated: 12:45 PM EDT, Apr 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Repligen Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

What's Going On With Life Science-Focused Repligen Stock Today? ↗

February 21, 2024

Repligen posts Q4 2023 results. CEO Tony Hunt highlights order strength in Filtration and Analytics. Positive momentum in new modalities; 2024 revenue forecast: $620-$650 million.

Via Benzinga

Earnings Scheduled For February 21, 2024 ↗

February 21, 2024

Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million.

Via Benzinga

Why Intel Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 26, 2024

Shares of Intel Corporation (NASDAQ: INTC) fell sharply during Friday’s session. Intel reported upbeat results for its fourth quarter, but issued a weak forecast for the first quarter.

Via Benzinga

Booz Allen Hamilton Posts Upbeat Results, Joins AppFolio, Gentex And Other Big Stocks Moving Higher On Friday ↗

January 26, 2024

U.S. stocks traded mixed, with the Dow Jones gaining around 80 points on Friday.

Via Benzinga

Topics Stocks

Analyst Ratings For Repligen ↗

December 20, 2023

Via Benzinga

How Good Is Your Market Cap Knowledge? ↗

January 11, 2024

A company with a $50 price per share might have a million shares outstanding or a billion shares outstanding. And unless you know, you don't know the price tag of the stock you're about to buy.

Via The Motley Fool

The Latest Analyst Ratings for Repligen ↗

December 04, 2023

Via Benzinga

Expedia Group, Gartner, Cloudflare, Cardinal Health And Other Big Stocks Moving Higher On Friday ↗

November 03, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Analyst Expectations for Repligen's Future ↗

November 02, 2023

Via Benzinga

Keybanc Maintains Overweight Rating for Repligen: Here's What You Need To Know ↗

November 01, 2023

Via Benzinga

Repligen Corp. (NASDAQ: RGEN) is a Leading Gainer in 10/31 Morning Trading

October 31, 2023

Via Investor Brand Network

A New Bull Market Is Coming! 3 Stocks Set to Soar 65% to 132% Higher ↗

November 01, 2023

Wall Street has high hopes for these stocks to buy for the next bull market. Consider adding them to your portfolio.

Via InvestorPlace

Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

October 31, 2023

Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for...

Via Benzinga

Topics Intellectual Property

A Preview Of Repligen's Earnings ↗

October 30, 2023

Via Benzinga

7 Analysts Have This to Say About Repligen ↗

October 17, 2023

Via Benzinga

What 6 Analyst Ratings Have To Say About Repligen ↗

September 06, 2023

Via Benzinga

Repligen's Strong Q3 Recovery: CEO Says Pharma Orders Rebound, Analytics Business Grows ↗

October 31, 2023

Repligen Corporation (NASDAQ: RGEN) reported third-quarter (Q3) revenues of $141.19 million, down 30% Y/Y, beating the

Via Benzinga

Arista Networks, JinkoSolar, Repligen, Shutterstock And Other Big Stocks Moving Higher On Tuesday ↗

October 31, 2023

U.S. stocks traded lower, with the Dow Jones falling more than 50 points on Tuesday. Here are some major stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Reviewing Mailbag Items and 5 Stocks Indistinguishable From Magic ↗

October 07, 2023

September wasn't a good month for the stock market, but there's plenty for investors to talk about.

Via The Motley Fool

Life Sciences Player Repligen's Strategic European Acquisition - What It Means for Investors ↗

September 26, 2023

Repligen Corporation (NASDAQ: RGEN) agreed to acquire Sweden-based privately-held Metenova.

Via Benzinga

What 4 Analyst Ratings Have To Say About Repligen ↗

July 06, 2023

Via Benzinga

Looking Into Repligen's Return On Capital Employed ↗

May 08, 2023

Via Benzinga

Earnings Scheduled For October 31, 2023 ↗

October 31, 2023

Companies Reporting Before The Bell • BBVA (NYSE:BBVA) is likely to report earnings for its third quarter. • BP (NYSE:BP) is expected to report quarterly earnings at $1.37 per share on revenue of...

Via Benzinga

Humana, Waters, e.l.f. Beauty, Teva Pharmaceutical And Other Big Stocks Moving Higher On Wednesday ↗

August 02, 2023

U.S. stocks traded lower, with the Dow Jones falling around 200 points on Wednesday. Here are some big stocks recording gains in today’s session. Powell Industries, Inc. (NASDAQ: POWL) shares jumped...

Via Benzinga

Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

October 25, 2023

Gainers Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholders approved its proposed business combination with DLQ.

Via Benzinga

Top 5 Health Care Stocks That May Collapse In July ↗

July 24, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2023 ↗

July 20, 2023

Via Benzinga

Over $6M Bet On This Financial Services Stock? Check Out These 3 Stocks Insiders Are Buying ↗

May 09, 2023

Although US stocks closed mixed on Monday, there were a few notable insider trades.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2023 ↗

July 06, 2023

Via Benzinga

Repligen Expects Slower Growth In APAC, Builds Portfolio On Heels Of FlexBiosys Deal ↗

May 02, 2023

Repligen Corp (NASDAQ: RGEN) reported Q1 FY23 sales of $182.66 million, down 12% Y/Y as reported,

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.